The 2025 Chinese Congress on Holistic Integrative Oncology (CCHIO) was held from November 6 to 9, 2025, in Kunming, Yunnan Province, China, gathering international experts, clinicians, and researchers committed to advancing integrative and holistic approaches in oncology.
The congress served as a major scientific event emphasizing the integration of conventional oncology, traditional Chinese medicine (TCM), and supportive care, with the goal of improving both treatment outcomes and the quality of life for patients with cancer.
Organizers and Institutional Collaboration
The event was hosted by the China Anti-Cancer Association (CACA) and the World Association of Integrative Oncology (WAIO), and jointly organized by Yunnan Cancer Hospital, Kunming Medical University, and the Yunnan Anti-Cancer Association.
This collaboration highlighted China’s growing leadership in promoting holistic models of care and fostering dialogue between Western medicine and traditional healing systems rooted in centuries of practice. The congress reflected a shared vision of strengthening the scientific foundation of integrative oncology while maintaining patient-centered care as its guiding principle.
A Record-Breaking Opening Ceremony
A defining moment of the congress was the Opening Ceremony on November 8, which achieved an extraordinary 78.52 million online views. This record-breaking engagement demonstrated the broad public and professional interest in integrative oncology and underscored the expanding global attention toward holistic approaches to cancer treatment and survivorship.
The remarkable reach of the event also reflected the increasing alignment between healthcare communication, digital platforms, and medical education making scientific knowledge accessible to both specialists and the general public.
Scientific Focus and Multidisciplinary Exchange
Over four days, the congress hosted a wide range of plenary sessions, expert lectures, and multidisciplinary discussions. The scientific program explored themes such as integrative immuno-oncology, the role of herbal and natural compounds in cancer management, personalized medicine within holistic care frameworks, and comprehensive approaches to rehabilitation and survivorship.
Experts emphasized the importance of rigorous clinical validation, collaborative research, and the establishment of international standards to ensure the safety, effectiveness, and reproducibility of integrative practices in oncology. The discussions also reflected the growing consensus that holistic approaches can complement modern medicine, improving patient well-being and adherence to treatment.
Bridging Traditional Wisdom and Modern Science
Throughout CCHIO 2025, a central theme emerged the harmonization of traditional wisdom and modern science. Participants highlighted that integrative oncology should not be viewed as an alternative to evidence-based medicine but as an expansion of it, enriching the scientific approach with cultural understanding, lifestyle medicine, and psychosocial support.
By combining innovation with compassion, the congress demonstrated how integrative oncology can contribute to global cancer control efforts, fostering a model of care that is both scientifically sound and deeply human.
A Vision for the Future
As the congress concluded, participating institutions reaffirmed their commitment to advancing integrative oncology through sustained research collaboration, clinical innovation, and international education. The success of CCHIO 2025 not only strengthened China’s leadership in this evolving field but also set the stage for continued cooperation among global oncology communities.
By bridging disciplines and cultures, the 2025 Chinese Congress on Holistic Integrative Oncology marked a milestone in redefining the future of cancer care one that embraces both the precision of science and the compassion of holistic healing.
CACA-SPCC-OncoDaily Summit 2025: Advancing Global Collaboration in Cancer Care
Written by Nare Hovhannisyan, MD
